TL
EVFM

TrueWealth LLC’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

TrueWealth LLC’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$0 Buy
+6
New +$404 ﹤0.01% 789

Other funds holding EVFM

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

TrueWealth LLC's EVFM Position: Q2 2020 in Review

TrueWealth LLC opened a new position in Evofem Biosciences, Inc. Common Stock (EVFM) in Q2 2020: 6 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #789 among its holdings.

122 funds tracked by Wall St. Rank hold EVFM as of Q2 2020.

  • TrueWealth LLC held 6 shares of Evofem Biosciences, Inc. Common Stock worth $0 as of Q2 2020.
  • Evofem Biosciences, Inc. Common Stock was a new TrueWealth LLC position in Q2 2020.
  • Evofem Biosciences, Inc. Common Stock made up ﹤0.01% of TrueWealth LLC's portfolio in Q2 2020, its #789 holding.
  • 122 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q2 2020.

Based on TrueWealth LLC's 13F filing for Q2 2020, filed 15 Jul 2020.